The novel approach of the medication represents a exciting breakthrough in the handling of the condition. Different to existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide642202.mybjjblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-54201451